NEW YORK (GenomeWeb) – WaferGen Bio-systems announced today that it has signed a deal to work with Roche subsidiary Genentech to evaluate and test its SmartChip platform in single-cell sequencing as part of an early-access program.

WaferGen said the companies will validate the SmartChip technology for isolating single cells from various tissues and preparing libraries for next-generation sequencing.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Human Longevity alleges that Craig Venter stole trade secrets in a lawsuit filed against the J. Craig Venter Institute.

A new analysis critiques the analysis and conclusions of the Atacama mummy genome sequencing study.

In PLOS this week: transcription levels linked to uracil mutations, transcriptomic analysis of medicinal leech, and more.

An Associated Press poll finds that most US adults say they'd want to know whether they carried a gene variant predisposing them to an incurable disease.